VIE •
Healthcare •
Biotechnology •
Quote as of 08/11/2026 16:42
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeVIE
Market Capitalization1,532.34 mln
Float24.23 mln
Earnings Date08/10/2026
EPS
7.41
Strong
P / E
3.28
Deeply undervalued
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
0.58
Highly suspicious
Relative Strength
33
/ 100
Underperforming
Debt / Equity
0.00
Debt-free
Business Description
Lakefront Biotherapeutics NV is a Belgian biotechnology company founded in 1999 and based in Mechelen, with operations across the United States and Europe. The company researches and develops treatments for cancer and immune system disorders, with several drugs currently in clinical trials targeting conditions such as lupus, lymphoma, and multiple myeloma. It works in partnership with Gilead Sciences and was previously known as Galapagos NV before changing its name in May 2026.
